
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
5 Elo 202545min

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
5 Elo 202545min

LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC
2 Elo 202547min

IASLC - Stigma
IASLC - Stigma by IASLC
29 Heinä 202557min

LCC in Japanese: ASCO 2025 Highlights
LCC in Japanese: ASCO 2025 Highlights by IASLC
25 Heinä 202534min

Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the ...
23 Heinä 202522min

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
18 Heinä 202545min

FDA Approval: Sunvozertinib for EGFR Exon 20
FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
15 Heinä 202541min
















